Heterogeneity has been consistent problem in the research and treatment of schizophrenia. Despite marked variation in the onset, phenomenology, treatment response and outcome of schizophrenics, our ability to identify subtypes is remarkably limited. A major problem in schizophrenia research has been the use of cross-sectional study designs and heterogeneous patient samples previously exposed to neuroleptics which have potentially confounding effects on the disease. This study proposes to identify biologic correlates of the phenomenology and course of schizophrenia by using a prospective, longitudinal, repeated measures design assessing biologic and clinical parameters in patients, from the onset of their illness. Preliminary results reveal significant abnormalities in brain morphology, growth hormone secretion and psychotogenic response to dopamine agonists in first episode treatment naive patients which are correlated with treatment response and outcome. Analyses further suggests the existence of distinct pathophysiologic processes, i.e. neurodevelopmental and neurodegenerative, and the presence of two subtypes of schizophrenia. This application is to continue the study for four years to complete patient entry, follow-up and data analysis. Upon completion approximately 120 first episode patients will have entered the study. They will be followed prospectively for at least three years and assessed at specific time intervals with measures of psychopathology, side effects and social adjustment to examine clinical variables of treatment response, illness course and outcome; measures of CNS DA activity and brain morphology. During the first of each subsequent episode we plan to treat all patients within a standardized treatment protocol to be able to characterize patients' treatment responsivity. Outpatient management will minimize drug exposure and, where clinically indicated attempt to withdraw patients from medication.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
2R01MH041646-04A2
Application #
3380372
Study Section
Biological Psychopathology Review Committee (BPP)
Project Start
1992-09-30
Project End
1996-06-30
Budget Start
1992-09-30
Budget End
1993-06-30
Support Year
4
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Long Island Jewish Medical Center
Department
Type
DUNS #
City
New Hyde Park
State
NY
Country
United States
Zip Code
11040
Umbricht, Daniel S G; Bates, John A; Lieberman, Jeffrey A et al. (2006) Electrophysiological indices of automatic and controlled auditory information processing in first-episode, recent-onset and chronic schizophrenia. Biol Psychiatry 59:762-72
Gunduz-Bruce, Handan; McMeniman, Marjorie; Robinson, Delbert G et al. (2005) Duration of untreated psychosis and time to treatment response for delusions and hallucinations. Am J Psychiatry 162:1966-9
Robinson, Delbert G; Woerner, Margaret G; McMeniman, Marjorie et al. (2004) Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 161:473-9
Woerner, Margaret G; Robinson, Delbert G; Alvir, Jose Ma J et al. (2003) Clozapine as a first treatment for schizophrenia. Am J Psychiatry 160:1514-6
Szeszko, Philip R; Gunning-Dixon, Faith; Goldman, Robert S et al. (2003) Lack of normal association between cerebellar volume and neuropsychological functions in first-episode schizophrenia. Am J Psychiatry 160:1884-7
Lencz, Todd; Bilder, Robert M; Turkel, Elihu et al. (2003) Impairments in perceptual competency and maintenance on a visual delayed match-to-sample test in first-episode schizophrenia. Arch Gen Psychiatry 60:238-43
Szeszko, Philip R; Gunning-Dixon, Faith; Ashtari, Manzar et al. (2003) Reversed cerebellar asymmetry in men with first-episode schizophrenia. Biol Psychiatry 53:450-9
Goldstein, Rita Z; Giovannetti, Tania; Schullery, Mathew et al. (2002) Neurocognitive correlates of response to treatment in formal thought disorder in patients with first-episode schizophrenia. Neuropsychiatry Neuropsychol Behav Neurol 15:88-98
Gunduz, Handan; Wu, Huwei; Ashtari, Manzar et al. (2002) Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects. Biol Psychiatry 51:801-8
Szeszko, Philip R; Strous, Rael D; Goldman, Robert S et al. (2002) Neuropsychological correlates of hippocampal volumes in patients experiencing a first episode of schizophrenia. Am J Psychiatry 159:217-26

Showing the most recent 10 out of 61 publications